Sabine U. Blum

Lausanne, VD 1011, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Acute myeloid leukemia in "fit" patients : updates on diagnosis and treatment

Acute myeloid leukemia in "fit" patients : updates on diagnosis and treatment

Journal: Revue medicale suisse

Published: September 03, 2026

Title Not Found

Title Not Found

Journal: Revue medicale suisse

Published: July 17, 2026

Evaluation of hyperferitinemia

Evaluation of hyperferitinemia

Journal: Revue medicale suisse

Published: June 26, 2026

Dose schedule modifications of 5-azacitidine monotherapy in myelodysplastic neoplasias and chronic myelomonocytic leukaemia.

Dose schedule modifications of 5-azacitidine monotherapy in myelodysplastic neoplasias and chronic myelomonocytic leukaemia.

Journal: Leukemia research

Published: May 08, 2026

Blinatumomab consolidation for high-risk Ph- B-cell acute lymphoblastic leukemia: the GRAALL-2014/B-QUEST study.

Blinatumomab consolidation for high-risk Ph- B-cell acute lymphoblastic leukemia: the GRAALL-2014/B-QUEST study.

Journal: Blood

Published: January 20, 2026

Blinatumomab Consolidation for High-Risk Ph-negative B-cell Acute Lymphoblastic Leukemia: the GRAALL-2014/B-QUEST Study.

Blinatumomab Consolidation for High-Risk Ph-negative B-cell Acute Lymphoblastic Leukemia: the GRAALL-2014/B-QUEST Study.

Journal: Blood

Published: January 20, 2026

Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countries.

Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countries.

Journal: Blood cancer journal

Published: December 19, 2025

Correspondance: Venetoclax combined with FLAG-based chemotherapy induces rapid and deep responses in early T-cell precursor lymphoblastic leukemia/lymphoma. Report of two cases and review of the literature.

Correspondance: Venetoclax combined with FLAG-based chemotherapy induces rapid and deep responses in early T-cell precursor lymphoblastic leukemia/lymphoma. Report of two cases and review of the literature.

Journal: Annals of hematology

Published: October 08, 2025

Spinal myeloid sarcoma as a first sign of acute myeloid leukaemia: A case report.

Spinal myeloid sarcoma as a first sign of acute myeloid leukaemia: A case report.

Journal: Radiology case reports

Published: September 27, 2025

Alternative 5-Azacitidine 5-Day 100 mg/m2 Dosage Shows Non-Inferiority to Classical Schedule for Myelodysplastic Neoplasm (MDS) and Chronic Myelomonocytic Leukaemia (CMML) Treatment.

Alternative 5-Azacitidine 5-Day 100 mg/m2 Dosage Shows Non-Inferiority to Classical Schedule for Myelodysplastic Neoplasm (MDS) and Chronic Myelomonocytic Leukaemia (CMML) Treatment.

Journal: EJHaem

Published: August 04, 2025

VEXAS syndrome: a Swiss national retrospective cohort study.

VEXAS syndrome: a Swiss national retrospective cohort study.

Journal: Swiss medical weekly

Published: March 25, 2025

Editorial: MDS: new scientific and clinical developments.

Editorial: MDS: new scientific and clinical developments.

Journal: Frontiers in oncology

Published: January 30, 2025

Showing 1-12 of 87

Last Updated: 09/26/2026